Ethypharm

Ethypharm is an independent pharmaceutical company with a global reach, specialising in pain and substance dependence therapies. Expanding its CNS product portfolio, Ethypharm aims to better serve patients and healthcare providers. Its wide range of injectable products addresses critical care needs in emergency and intensive care units. Additionally, Ethypharm develop complex generics that optimise healthcare costs.

Spectrum Community Health CIC provides quality healthcare for people in vulnerable circumstances. They work in partnership to provide primary care, substance misuse and sexual health services, in the community and in secure environments including prisons, hospitals and immigration centers. As a not-for-profit social business, they are committed to addressing health inequalities and investing into the health and wellbeing of the communities they serve.

Hep C U Later is a national NHS initiative commissioned NHS England’s Viral Hepatitis Elimination Programme, aimed at supporting the elimination of viral hepatitis through providing on the ground support, resources, education, communications and engagement with professionals.  Hep C U Later’s free resources are available here.

Project 6

Project 6 is an award-winning drug and alcohol charity working across West and South Yorkshire. We have been delivering services for people experiencing challenges connected to drug and alcohol use and multiple disadvantage in our local communities for over 35 years.

We are a harm-reduction and recovery-focused service, working to help people reduce the risks associated with substance use and we offer highly effective, evidence-based support to people and families using alcohol and other drugs.

Tees, Esk & Wear Valleys NHS Foundation Trust are a Mental Health & Learning Disability NHS Trust for County Durham and Darlington, Teesside, North Yorkshire, York and Selby.

From education and prevention to crisis and specialist care; our talented and compassionate teams work in partnership with our patients, communities and partners to help the people of our region feel safe, understood, believed in and cared for.

They nurture the recovery journey of anyone in need of our help. In their Trust, everyone has a say in how they are supported and treated because they listen to every person in their care until they feel understood. Their patients, families and carers work together with them towards better mental health.

They're committed to new thinking that improves the wellbeing of their region. They connect with their communities and partners to get mental health care right, in areas that really need it.

They won’t rest until everyone in our region has the mental health care they need, to lead their best possible life.

North East Area Drug Detection Dog Team

The Northeast Area Drug Detection Dog Team plays a vital role in supporting prisons across the region by preventing the supply of illicit drugs and other prohibited items. Working across multiple establishments, the team provides specialist searching capability using highly trained detection dogs and experienced handlers.

The team delivers both planned and reactive support, assisting establishments with security operations, intelligence-led searches, visits, reception activity, and incidents of emerging risk. Their work is central to disrupting criminal activity, reducing the availability of drugs, and supporting safer, more stable prison environments.

Through professionalism, skill, and close partnership working with prison staff and security teams, the North East Area Drug Detection Dog Team makes a significant contribution to protecting staff, prisoners, and the wider public helping to keep prisons safe, secure, and focused on rehabilitation.

Camurus

Camurus is a Swedish science-led pharmaceutical company committed to developing and commercialising innovative and long-acting medicines for the treatment of severe and chronic diseases.
We focus on diseases of the central nervous system, rare diseases, endocrine disorders,
oncology and supportive care.

FluidCrystal is Camurus’ patent-protected technology that, when combined with active pharmaceutical compounds with established efficacy and safety characteristics or new chemical entities, offers the promise of improvements in treatment outcomes, convenience and quality of life for people with serious and chronic diseases whilst also having the potential to improve the utilisation of resources in the healthcare system.

Founded in 2017, RESET began as a mutual-aid support group for soldiers at Catterick Garrison struggling with addiction.
In partnership with North Yorkshire Horizons the initiative evolved into a bespoke service addressing the unique challenges of addictive behaviours within all branches of the Armed Forces regardless of rank, age, unit or gender. Defence Medical Services recognise 'lived experience and peer support' as best practice for recovery and RESET have supported several hundred personnel to remain in service and operationally deployable, working with Welfare Specialists and healthcare professionals.
RESET continues to transform lives and enhance operational readiness through recovery.